Sorafenib has been identified as RAF1 and BRaf protein kinase inhibitor and has been reported to inhibit viral infectivity by downregulating ERK/MAPK signaling pathways during viral infection [86]. The gene discussed is MAPK1; the disease is viral infectious disease.